Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -159.30% is 143% below its 5-year average of -65.55%, near the low end of its 5-year range (-159.30%–-16.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.66% below its 12-month average of -121.00%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -159.30%.
RETURN ON INVESTED CAPITAL (ROIC)
-159.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-121.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-88.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-65.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-96.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-69.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.66%
CURRENT VS 3Y AVG
-79.97%
CURRENT VS 5Y AVG
-143.02%
CURRENT VS 10Y AVG
-65.26%
CURRENT VS 15Y AVG
-129.08%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 664 covered companies
CURRENT VS SECTOR MEDIAN
-377.17%
vs the sector median at left
Cardiff Oncology, Inc.
Market Cap
$85.17M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-121.00%
3Y Avg
-88.52%
5Y Avg
-65.55%
Market Cap
$85.01M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-639.99%
3Y Avg
-358.78%
5Y Avg
-266.51%
Market Cap
$85.09M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$85.01M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
Market Cap
$84.61M
Return on Invested Capital (ROIC)
-87.79%
TTM Avg
-271.72%
3Y Avg
-628154.34%
5Y Avg
-503132.91%
Market Cap
$86.90M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$83.21M
Return on Invested Capital (ROIC)
-126.99%
TTM Avg
-110.63%
3Y Avg
-85.52%
5Y Avg
-67.36%
Market Cap
$83.18M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-27.86%
3Y Avg
-23.01%
5Y Avg
-20.58%
Market Cap
$83.04M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | $85.17M | -159.30% | -121.00% | -88.52% | -65.55% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.01M | -100.35% | -639.99% | -358.78% | -266.51% |
| Humacyte, Inc. (HUMA)vs › | $85.09M | -90.27% | -103.33% | -85.38% | -72.83% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | -109.43% | -208.02% | -178.83% | -203.50% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.61M | -87.79% | -271.72% | -628154.34% | -503132.91% |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 12.79% | 17.38% | -11.40% | -8.36% |
| Nutriband Inc. (NTRB)vs › | $83.21M | -126.99% | -110.63% | -85.52% | -67.36% |
| MediciNova, Inc. (MNOV)vs › | $83.18M | -31.62% | -27.86% | -23.01% | -20.58% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | -88.28% | -61.59% | -48.92% | -67.61% |
| LENSAR Inc (LNSR)vs › | $82.10M | -16.28% | -50.22% | -41.74% | -37.86% |
ROIC
-159.3%
ROE
-150.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -159.30% |
| 2026-03-31 | -136.64% |
| 2025-12-31 | -107.63% |
| 2025-09-30 | -109.44% |
| 2025-06-30 | -91.98% |
| 2025-03-31 | -72.85% |
| 2024-12-31 | -58.08% |
| 2024-09-30 | -92.14% |
| 2024-06-30 | -83.38% |
| 2024-03-31 | -71.22% |
| 2023-12-31 | -63.78% |
| 2023-09-30 | -55.99% |
| 2023-06-30 | -48.28% |
| 2023-03-31 | -41.54% |
| 2022-12-31 | -36.82% |
| 2022-09-30 | -34.70% |
| 2022-06-30 | -30.98% |
| 2022-03-31 | -26.02% |
| 2021-12-31 | -20.18% |
| 2021-09-30 | -18.95% |
| 2021-06-30 | -16.67% |
| 2021-03-31 | -16.31% |
| 2020-12-31 | -14.84% |
| 2020-09-30 | -49.19% |
| 2020-06-30 | -66.26% |
| 2020-03-31 | -242.87% |
| 2019-12-31 | -200.83% |
| 2019-09-30 | -212.77% |
| 2019-06-30 | -158.65% |
| 2019-03-31 | -145.46% |
| 2018-12-31 | -152.17% |
| 2018-09-30 | -109.70% |
| 2018-06-30 | -100.68% |
| 2018-03-31 | -260.36% |
| 2017-12-31 | -264.68% |
| 2017-09-30 | -366.35% |
| 2017-06-30 | -529.73% |
| 2017-03-31 | -138.04% |
| 2016-12-31 | -104.24% |
| 2016-09-30 | -79.91% |
| 2016-06-30 | -65.86% |
| 2016-03-31 | -50.03% |
| 2015-12-31 | -36.91% |
| 2015-09-30 | -30.34% |
| 2015-06-30 | -48.58% |
| 2015-03-31 | -37.93% |
| 2014-12-31 | -56.81% |
| 2014-09-30 | -43.73% |
| 2014-06-30 | -36.32% |
| 2014-03-31 | -51.09% |
| 2013-12-31 | -42.18% |
| 2013-09-30 | -33.20% |
| 2013-06-30 | -87.98% |
| 2013-03-31 | -67.70% |
| 2012-12-31 | -44.34% |
| 2012-09-30 | -54.93% |
| 2012-06-30 | -45.72% |
